Stockreport

Salarius Pharmaceuticals Regains Compliance with All Nasdaq Listing Requirements [Yahoo! Finance]

Salarius Pharmaceuticals, Inc.  (SLRX) 
PDF or the Company) announces that on October 10, 2025 the Company received notice from the Nasdaq Stock Market LLC (Nasdaq) that it has regained compliance with Nasdaq List [Read more]